List of Tables
Table 1. Global Self-administered Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Insulin
Table 3. Key Players of GLP-1 Receptor Agonists
Table 4. Key Players of rhGH
Table 5. Key Players of Subcutaneous mAbs
Table 6. Key Players of Other
Table 7. Global Self-administered Biologics Market Size Growth Rate by Delivery Device Type (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Pre-filled syringe pens
Table 9. Key Players of Auto-injectors
Table 10. Key Players of Wearable infusion devices
Table 11. Key Players of Others
Table 12. Global Self-administered Biologics Market Size Growth Rate by Technological Characteristics (US$ Million): 2020 VS 2024 VS 2031
Table 13. Key Players of Conventional Liquid Formulations
Table 14. Key Players of Sustained/Extended-release Biologics
Table 15. Key Players of Lyophilized Ready-to-use Formulations
Table 16. Global Self-administered Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Self-administered Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Self-administered Biologics Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Self-administered Biologics Market Share by Region (2020-2025)
Table 20. Global Self-administered Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Self-administered Biologics Market Share by Region (2026-2031)
Table 22. Self-administered Biologics Market Trends
Table 23. Self-administered Biologics Market Drivers
Table 24. Self-administered Biologics Market Challenges
Table 25. Self-administered Biologics Market Restraints
Table 26. Global Self-administered Biologics Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Self-administered Biologics Market Share by Players (2020-2025)
Table 28. Global Top Self-administered Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-administered Biologics as of 2024)
Table 29. Ranking of Global Top Self-administered Biologics Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Self-administered Biologics Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Self-administered Biologics, Headquarters and Area Served
Table 32. Global Key Players of Self-administered Biologics, Product and Application
Table 33. Global Key Players of Self-administered Biologics, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Self-administered Biologics Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Self-administered Biologics Revenue Market Share by Type (2020-2025)
Table 37. Global Self-administered Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Self-administered Biologics Revenue Market Share by Type (2026-2031)
Table 39. Global Self-administered Biologics Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Self-administered Biologics Revenue Market Share by Application (2020-2025)
Table 41. Global Self-administered Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Self-administered Biologics Revenue Market Share by Application (2026-2031)
Table 43. North America Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Self-administered Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Self-administered Biologics Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Self-administered Biologics Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 58. Novo Nordisk Company Details
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Self-administered Biologics Product
Table 61. Novo Nordisk Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 62. Novo Nordisk Recent Development
Table 63. Sanofi-Aventis Company Details
Table 64. Sanofi-Aventis Business Overview
Table 65. Sanofi-Aventis Self-administered Biologics Product
Table 66. Sanofi-Aventis Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 67. Sanofi-Aventis Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Self-administered Biologics Product
Table 71. Eli Lilly Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Tonghua Dongbao Company Details
Table 74. Tonghua Dongbao Business Overview
Table 75. Tonghua Dongbao Self-administered Biologics Product
Table 76. Tonghua Dongbao Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 77. Tonghua Dongbao Recent Development
Table 78. United Laboratory Company Details
Table 79. United Laboratory Business Overview
Table 80. United Laboratory Self-administered Biologics Product
Table 81. United Laboratory Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 82. United Laboratory Recent Development
Table 83. Biocon Company Details
Table 84. Biocon Business Overview
Table 85. Biocon Self-administered Biologics Product
Table 86. Biocon Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 87. Biocon Recent Development
Table 88. GSK Company Details
Table 89. GSK Business Overview
Table 90. GSK Self-administered Biologics Product
Table 91. GSK Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 92. GSK Recent Development
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Self-administered Biologics Product
Table 96. Bristol-Myers Squibb Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Ganlee Company Details
Table 99. Ganlee Business Overview
Table 100. Ganlee Self-administered Biologics Product
Table 101. Ganlee Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 102. Ganlee Recent Development
Table 103. Julphar Diabetes Company Details
Table 104. Julphar Diabetes Business Overview
Table 105. Julphar Diabetes Self-administered Biologics Product
Table 106. Julphar Diabetes Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 107. Julphar Diabetes Recent Development
Table 108. Wockhardt Company Details
Table 109. Wockhardt Business Overview
Table 110. Wockhardt Self-administered Biologics Product
Table 111. Wockhardt Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 112. Wockhardt Recent Development
Table 113. Viatris Company Details
Table 114. Viatris Business Overview
Table 115. Viatris Self-administered Biologics Product
Table 116. Viatris Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 117. Viatris Recent Development
Table 118. BD Company Details
Table 119. BD Business Overview
Table 120. BD Self-administered Biologics Product
Table 121. BD Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 122. BD Recent Development
Table 123. Johnson & Johnson Company Details
Table 124. Johnson & Johnson Business Overview
Table 125. Johnson & Johnson Self-administered Biologics Product
Table 126. Johnson & Johnson Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 127. Johnson & Johnson Recent Development
Table 128. Amgen Company Details
Table 129. Amgen Business Overview
Table 130. Amgen Self-administered Biologics Product
Table 131. Amgen Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 132. Amgen Recent Development
Table 133. Biogen Idec Company Details
Table 134. Biogen Idec Business Overview
Table 135. Biogen Idec Self-administered Biologics Product
Table 136. Biogen Idec Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 137. Biogen Idec Recent Development
Table 138. Bayer Company Details
Table 139. Bayer Business Overview
Table 140. Bayer Self-administered Biologics Product
Table 141. Bayer Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 142. Bayer Recent Development
Table 143. Pfizer Company Details
Table 144. Pfizer Business Overview
Table 145. Pfizer Self-administered Biologics Product
Table 146. Pfizer Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 147. Pfizer Recent Development
Table 148. Roche Company Details
Table 149. Roche Business Overview
Table 150. Roche Self-administered Biologics Product
Table 151. Roche Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 152. Roche Recent Development
Table 153. AbbVie Company Details
Table 154. AbbVie Business Overview
Table 155. AbbVie Self-administered Biologics Product
Table 156. AbbVie Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 157. AbbVie Recent Development
Table 158. Takeda Pharmaceutical Company Details
Table 159. Takeda Pharmaceutical Business Overview
Table 160. Takeda Pharmaceutical Self-administered Biologics Product
Table 161. Takeda Pharmaceutical Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 162. Takeda Pharmaceutical Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Self-administered Biologics Picture
Figure 2. Global Self-administered Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Self-administered Biologics Market Share by Type: 2024 VS 2031
Figure 4. Insulin Features
Figure 5. GLP-1 Receptor Agonists Features
Figure 6. rhGH Features
Figure 7. Subcutaneous mAbs Features
Figure 8. Other Features
Figure 9. Global Self-administered Biologics Market Size Comparison by Delivery Device Type (2020-2031) & (US$ Million)
Figure 10. Pre-filled syringe pens Features
Figure 11. Auto-injectors Features
Figure 12. Wearable infusion devices Features
Figure 13. Others Features
Figure 14. Global Self-administered Biologics Market Size Comparison by Technological Characteristics (2020-2031) & (US$ Million)
Figure 15. Conventional Liquid Formulations Features
Figure 16. Sustained/Extended-release Biologics Features
Figure 17. Lyophilized Ready-to-use Formulations Features
Figure 18. Global Self-administered Biologics Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Self-administered Biologics Market Share by Application: 2024 VS 2031
Figure 20. Diabetes Case Studies
Figure 21. Rheumatoid Arthritis Case Studies
Figure 22. Anaphylaxis Case Studies
Figure 23. Others Case Studies
Figure 24. Self-administered Biologics Report Years Considered
Figure 25. Global Self-administered Biologics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 26. Global Self-administered Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 27. Global Self-administered Biologics Market Share by Region: 2024 VS 2031
Figure 28. Global Self-administered Biologics Market Share by Players in 2024
Figure 29. Global Self-administered Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Self-administered Biologics Revenue in 2024
Figure 31. North America Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. North America Self-administered Biologics Market Share by Country (2020-2031)
Figure 33. United States Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Canada Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Europe Self-administered Biologics Market Share by Country (2020-2031)
Figure 37. Germany Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. France Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. U.K. Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Italy Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Russia Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Ireland Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Self-administered Biologics Market Share by Region (2020-2031)
Figure 45. China Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Japan Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. South Korea Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. India Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Australia & New Zealand Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Latin America Self-administered Biologics Market Share by Country (2020-2031)
Figure 53. Mexico Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Brazil Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Middle East & Africa Self-administered Biologics Market Share by Country (2020-2031)
Figure 57. Israel Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. UAE Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. Novo Nordisk Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 61. Sanofi-Aventis Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 63. Tonghua Dongbao Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 64. United Laboratory Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 65. Biocon Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 66. GSK Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 68. Ganlee Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 69. Julphar Diabetes Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 70. Wockhardt Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 71. Viatris Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 72. BD Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 73. Johnson & Johnson Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 74. Amgen Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 75. Biogen Idec Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 76. Bayer Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 77. Pfizer Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 78. Roche Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 79. AbbVie Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 80. Takeda Pharmaceutical Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
